0001479290-19-000103.txt : 20191015 0001479290-19-000103.hdr.sgml : 20191015 20191015202304 ACCESSION NUMBER: 0001479290-19-000103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191013 FILED AS OF DATE: 20191015 DATE AS OF CHANGE: 20191015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Foley Mark J CENTRAL INDEX KEY: 0001529196 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 191151870 MAIL ADDRESS: STREET 1: ZELTIQ AESTHETICS INC. STREET 2: 4698 WILLOW ROAD SUITE 100 CITY: PLEASANTON STATE: CA ZIP: 94588 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-742-3400 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 4 1 wf-form4_157118535567459.xml FORM 4 X0306 4 2019-10-13 0 0001479290 Revance Therapeutics, Inc. RVNC 0001529196 Foley Mark J C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BLVD. NEWARK CA 94560 1 1 0 0 CEO & President Common Stock 2019-10-13 4 A 0 200000 0 A 213500 D Common Stock 20000 I See footnote Employee Stock Option (Right to Buy) 12.18 2019-10-13 4 A 0 740000 0 A 2029-10-12 Common Stock 740000.0 740000 D The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from October 13, 2019, subject to Mr. Foley's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date. These shares are held by the Mark and Dana Foley, Trustees, Foley Family Trust U/A DTD 4/10/2002. The fair market value was determined on October 11,2019 pursuant to the Plan. The Option vests in accordance to the following schedule: 25% of the shares subject to the Option shall vest on the first anniversary of the vesting commencement date of October 13, 2019, and 1/48th of the shares vesting each month thereafter for the remaining three years, subject to Mr. Foley's Continuous Service (as defined in the Plan) as of each such vesting date. /s/ Gordon Ho, Attorney-in-Fact 2019-10-15